GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (LTS:0J4V) » Definitions » E10

Heron Therapeutics (LTS:0J4V) E10 : $-3.01 (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Heron Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Heron Therapeutics's adjusted earnings per share data for the three months ended in Jun. 2024 was $-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-3.01 for the trailing ten years ended in Jun. 2024.

During the past 3 years, the average E10 Growth Rate was -0.30% per year. During the past 5 years, the average E10 Growth Rate was 1.70% per year. During the past 10 years, the average E10 Growth Rate was 22.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Heron Therapeutics was 64.20% per year. The lowest was -90.10% per year. And the median was 14.80% per year.

As of today (2024-09-21), Heron Therapeutics's current stock price is $1.9488. Heron Therapeutics's E10 for the quarter that ended in Jun. 2024 was $-3.01. Heron Therapeutics's Shiller PE Ratio of today is .


Heron Therapeutics E10 Historical Data

The historical data trend for Heron Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics E10 Chart

Heron Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.64 -3.15 -3.69 -3.52 -3.23

Heron Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.46 -3.25 -3.23 -3.12 -3.01

Competitive Comparison of Heron Therapeutics's E10

For the Biotechnology subindustry, Heron Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heron Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's Shiller PE Ratio falls into.



Heron Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Heron Therapeutics's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-0.06/132.5538*132.5538
=-0.060

Current CPI (Jun. 2024) = 132.5538.

Heron Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201409 -0.660 100.428 -0.871
201412 -0.710 99.070 -0.950
201503 -0.700 99.621 -0.931
201506 -0.740 100.684 -0.974
201509 -0.630 100.392 -0.832
201512 -0.870 99.792 -1.156
201603 -0.920 100.470 -1.214
201606 -1.170 101.688 -1.525
201609 -1.240 101.861 -1.614
201612 -1.220 101.863 -1.588
201703 -1.000 102.862 -1.289
201706 -0.800 103.349 -1.026
201709 -0.770 104.136 -0.980
201712 -1.100 104.011 -1.402
201803 -0.810 105.290 -1.020
201806 -0.540 106.317 -0.673
201809 -0.490 106.507 -0.610
201812 -0.630 105.998 -0.788
201903 -0.800 107.251 -0.989
201906 -0.630 108.070 -0.773
201909 -0.420 108.329 -0.514
201912 -0.650 108.420 -0.795
202003 -0.570 108.902 -0.694
202006 -0.610 108.767 -0.743
202009 -0.640 109.815 -0.773
202012 -0.680 109.897 -0.820
202103 -0.580 111.754 -0.688
202106 -0.620 114.631 -0.717
202109 -0.510 115.734 -0.584
202112 -0.540 117.630 -0.609
202203 -0.630 121.301 -0.688
202206 -0.550 125.017 -0.583
202209 -0.380 125.227 -0.402
202212 -0.170 125.222 -0.180
202303 -0.270 127.348 -0.281
202306 -0.350 128.729 -0.360
202309 -0.170 129.860 -0.174
202312 -0.050 129.419 -0.051
202403 -0.020 131.776 -0.020
202406 -0.060 132.554 -0.060

Add all the adjusted EPS together and divide 10 will get our e10.


Heron Therapeutics  (LTS:0J4V) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Heron Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Heron Therapeutics Business Description

Traded in Other Exchanges
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics Headlines

No Headlines